Is (14C)-Glycocholic Acid safe while breastfeeding?
Here is what LactMed, the Drugs and Lactation Database published by the U.S. National Institute of Child Health and Human Development (NICHD), reports about (14C)-Glycocholic Acid. The text below is quoted from that source — it is not our own verdict.
Summary of use during breastfeeding
Information in this record refers to the use of (14C)-glycocholic acid as a diagnostic agent. Breastfeeding does not need to be suspended after administration of (14C)-glycocholic acid.[1,2]
Effects on the breastfed infant
Relevant published information was not found as of the revision date.
Effects on milk supply
Relevant published information was not found as of the revision date.
Levels in milk
Carbon 14 is a low-energy beta emitter with a physical half-life of about 5730 years. (14C)- glycocholic acid has an effective half-life of 143 hours. Approximately 9.2% of the injected radioactivity is excreted into breastmilk.[1]
Source: Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development (NICHD), via NCBI Bookshelf, record “(14C)-Glycocholic Acid” (LM1214). LactMed on NCBI Bookshelf. LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Educational summary of an authoritative source — not medical advice. Never start, stop, or change a medicine while breastfeeding without confirming with your doctor.